Articles tagged "Kidney transplantation"

2016 American Transplant Congress
Long-Term Efficacy and Safety of Everolimus Based Immunosuppression on De Novo Kidney Transplantation with 7 Years Follow-Up.
Y. Watarai, M. Okada, K. Futamura, T. Nagai, T. Yamamoto, M. Tsujita, T. Hiramitsu, N. Goto, S. Narumi, T. Kobayashi.
Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan; Kidney Transplant Surgery, Aichi Medical University, Nagoya, Aichi, Japan.
Purpose: Long-term efficacy and safety of everolimus (EVR) based immunosuppression for de novo kidney transplant recipient who were involved in A1202 study from our institute…
2016 American Transplant Congress
Acute Rejections and Incidence of De Novo DSA Depend on Donor Factors and Deceased Donor Kidney Associated Risk Assessed by the Kidney Donor Profile Index (KDPI).
O. Staeck, D. Khadzhynov, L. Lehner, A. Kleinsteuber, M. Duerr, E. Schrezenmeier, K. Budde, F. Halleck.
Nephrology, Charite, Berlin, Germany.
Introduction: Little data exist analyzing the influence of donor kidney quality on the immunologic outcome and applying the KDPI in a European cohort.Methods: This retrospective…
2016 American Transplant Congress
The UKKDRI Score Predicts Outcomes of Deceased Donor Transplantation Using a Steroid Sparing Immunosuppressive Protocol.
A. Wardle, M. Willicombe, D. Goodall, A. McLean, D. Taube.
Imperial College REnal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.
The UK kidney donor risk-index (UKKDRI) was developed to provide a simplistic clinical tool to help determine quality of an allograft and aid informed consent.…
2016 American Transplant Congress
Thorough Pre-Transplant Evaluation and Appropriate Case Selection Is the Mainstay for Better Survival in Recipients with Malignancy.
W. Yin.^1,2
¹Surgery, School of Medicine, Tzu Chi University, Hualien, Taiwan; ²Surgery, Dalin Tzu Chi General Hospital, Chia-I, Taiwan.
IntroductionMalignancy has become one of the three major causes of death after transplantation in the past decade and is thus increasingly important in all organ…
2016 American Transplant Congress
Urine IP-10 as the Biomarker for ABMR in Kidney Transplant Recipient with DGF.
N. Townamchai,¹ A. Leelahavanichakul,² J. Supapol,³ S. Wattanatorn,¹ Y. Avihingsanon,¹ K. Praditpornsilpa.¹
¹Department of Medicine, Division of Nephrology, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand; ²Department of Microbiology, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand; ³Department of Surgery, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Background: In the setting of DGF in kidney transplantation (KT), early acute ABMR, which needs early treatment, has to be differentiated from simple ischemic acute…
2016 American Transplant Congress
Outcomes in Obese Renal Transplant Recipients Using High versus Low-Dose Thymoglobulin.
N. Jasiak,¹ C. Stromayer,¹ J. Thielke,¹ J. Chen,² J. Chen,¹ B. Talon,¹ R. Rubin-Tobar,¹ E. Benedetti,² P. West-Thielke.^1,2
¹Pharmacy, University of Illinois, Chicago; ²Transplant Surgery, University of Illinois, Chicago, IL.
Background: Dosing of rabbit anti-thymocyte globulin (rATG) induction in renal transplant recipients is highly variable by transplant center. Optimizing rATG dose becomes extremely important for…
2016 American Transplant Congress
Reciprocal Effects of HDAC1 and HDAC2 Deletion on Renal Cold Ischemia Survival and Nuclear Co-Repressor Complex Expression.
D. Aufhauser Jr,¹ D. Murken,¹ Z. Wang,¹ A. Samanta,² G. Ge,¹ T. Bhatti,³ W. Hancock,^2,3 M. Levine.¹
¹Surgery, University of Pennsylvania, Philadelphia, PA; ²Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA; ³Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA.
Introduction: Class I histone/protein deacetylases (HDACs) 1 and 2 bear >85% protein sequence homology and conventionally are thought to have similar function via occupancy in…
2016 American Transplant Congress
Living Kidney Donor Priorities for Outcomes: A Nominal Group Technique Study.
C. Hanson,^1,2 J. Kanellis,^3,4 G. Wong,^1,2 J. Pinter,² S. Chadban,^5,6 J. Chapman,⁷ J. Craig,^1,2 J. Gill,⁸ A. Garg,⁹ J. Lewis,^1,2 A. Tong.^1,2
¹Sydney School of Public Health, University of Sydney, Sydney, Australia; ²Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia; ³Department of Medicine, Monash University, Melbourne, Australia; ⁴Department of Nephrology, Monash Medical Centre, Melbourne, Australia; ⁵Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia; ⁶Sydney Medical School, The University of Sydney, Sydney, Australia; ⁷Centre for Transplant and Renal Research, Westmead Hospital, Sydney, Australia; ⁸Division of Nephrology, University of British Columbia, Vancouver, Canada; ⁹Division of Nephrology, Department of Medicine, Western University, London, Canada.
Background: Living kidney donors face risks associated with nephrectomy. While this is justified with informed consent, screening and follow up, the outcomes that are most…
2016 American Transplant Congress
Comparison of Outcomes of Kidney Transplantation from DBD, DCD or DBCD Donors: A Single Center Experience from China.
G. Chen, C. Wang, L. Chen, J. Qiu, C. Wang.
Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Background There are three categories of deceased donors in China now, donation after brain death(DBD), donation of cardiac death(DCD), and donation after brain and cardiac…
2016 American Transplant Congress
Comparison of Surgical Correction Techniques for Post-Kidney Transplantation Vesicoureteral Reflux.
V. Turunç,¹ A. Eroğlu,² B. Tabandeh,¹ H. Dheir,² E. Basok,³ A. Erol.³
¹Department of General Surgery, Bahçesehir University, Faculty of Medicine, İstanbul, Turkey; ²Organ Transplantation Center, Göztepe Medical Park Hospital, İstanbul, Turkey; ³Department of Urology, Bahçesehir University, Faculty of Medicine, İstanbul, Turkey.
PURPOSEThe aim of this study was to compare extravesical seromuscular tunnel lengthening technique with uretero-ureteral/pyelo-ureteral anastomosis techniques in post-transplant vesicoureteral reflux (VUR) management.MATERIALS AND METHODSWe…